Skip to main content

TSX Information Tech Capped Index(TTTK)
INDEX/TSX

Today's Change
Real-Time Last Update

Nature's Sunshine (NASDAQ:NATR) Reports Q1 In Line With Expectations

StockStory - Tue May 7, 3:51PM CDT

NATR Cover Image

Wellness products company Nature’s Sunshine Products (NASDAQ:NATR) reported results in line with analysts' expectations in Q1 CY2024, with revenue up 2.2% year on year to $111 million. The company's outlook for the full year was also close to analysts' estimates with revenue guided to $467.5 million at the midpoint. It made a non-GAAP profit of $0.12 per share, improving from its profit of $0.04 per share in the same quarter last year.

Is now the time to buy Nature's Sunshine? Find out by accessing our full research report, it's free.

Nature's Sunshine (NATR) Q1 CY2024 Highlights:

  • Revenue: $111 million vs analyst estimates of $111.2 million (small miss)
  • EPS (non-GAAP): $0.12 vs analyst expectations of $0.17 (29.4% miss)
  • The company reconfirmed its revenue guidance for the full year of $467.5 million at the midpoint
  • Gross Margin (GAAP): 71.2%, in line with the same quarter last year
  • Free Cash Flow was -$1.50 million, down from $8.35 million in the previous quarter
  • Market Capitalization: $359.4 million

Started on a kitchen table in Utah, Nature’s Sunshine Products (NASDAQ:NATR) manufactures and sells nutritional and personal care products.

Personal Care

While personal care products products may seem more discretionary than food, consumers tend to maintain or even boost their spending on the category during tough times. This phenomenon is known as "the lipstick effect" by economists, which states that consumers still want some semblance of affordable luxuries like beauty and wellness when the economy is sputtering. Consumer tastes are constantly changing, and personal care companies are currently responding to the public’s increased desire for ethically produced goods by featuring natural ingredients in their products.

Sales Growth

Nature's Sunshine is a small consumer staples company, which sometimes brings disadvantages compared to larger competitors benefitting from better brand awareness and economies of scale.

As you can see below, the company's annualized revenue growth rate of 4.6% over the last three years was weak for a consumer staples business.

Nature's Sunshine Total Revenue

This quarter, Nature's Sunshine's revenue grew 2.2% year on year to $111 million, falling short of Wall Street's estimates. Looking ahead, Wall Street expects sales to grow 6% over the next 12 months, an acceleration from this quarter.

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.

Cash Is King

Although earnings are undoubtedly valuable for assessing company performance, we believe cash is king because you can't use accounting profits to pay the bills.

Nature's Sunshine burned through $1.50 million of cash in Q1, representing a negative 1.4% free cash flow margin. The company shifted to cash flow negative from cash flow positive in the same quarter last year, which caught our eye as we'd like consumer staples companies to have more consistent performance.

Nature's Sunshine Free Cash Flow Margin

Over the last eight quarters, Nature's Sunshine has shown mediocre cash profitability, putting it in a pinch as it gives the company limited opportunities to reinvest, pay down debt, or return capital to shareholders. Its free cash flow margin has averaged 3.7%, subpar for a consumer staples business. However, its margin has averaged year-on-year increases of 2.7 percentage points over the last 12 months. Continued momentum should improve its cash flow prospects.

Key Takeaways from Nature's Sunshine's Q1 Results

The company's operating margin and EPS both missed analysts' expectations. Full year revenue guidance was maintained and is in line with expectations. Overall, this was a mediocre quarter for Nature's Sunshine. The company is down 1.4% on the results and currently trades at $18.75 per share.

Nature's Sunshine may have had a tough quarter, but does that actually create an opportunity to invest right now? When making that decision, it's important to consider its valuation, business qualities, as well as what has happened in the latest quarter. We cover that in our actionable full research report which you can read here, it's free.

More from The Globe

opinion
Here’s what really drives your returns